APO Research
Talk to an analyst

APO RESEARCH · REPORT

Verapamil Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Verapamil Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchVerapamil Hydrochloride Injection Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Verapamil Hydrochloride Injection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Verapamil Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Verapamil Hydrochloride Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Verapamil Hydrochloride Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Verapamil Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Verapamil Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Verapamil Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Verapamil Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Verapamil Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Verapamil Hydrochloride Injection include ACIC Pharmaceuticals, Exela Pharma, Gland Pharma, Mankind Pharma, Duoduo Pharmaceutical, Harbin Pharm. Group Sanjing Pharmaceutical, Hubei Weishi, China Res Double-Crane and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Verapamil Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Verapamil Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Verapamil Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Verapamil Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Verapamil Hydrochloride Injection Segment by Company

ACIC Pharmaceuticals

Exela Pharma

Gland Pharma

Mankind Pharma

Duoduo Pharmaceutical

Harbin Pharm. Group Sanjing Pharmaceutical

Hubei Weishi

China Res Double-Crane

Pfizer

Jilin Jinsheng Pharmaceutical

Jiangsu Langou Drug

Jiangsu Ruinian Qianjin Pharmacy

Zydus Pharmaceuticals

Shanghai Harvest Pharmaceutical

Shiyao YINHU Pharmaceutical

Chia Tai-Tianqing Pharmaceutical

Chongqing Yaoyou Pharmacy

Verapamil Hydrochloride Injection Segment by Type

Oral

Intravenous Injection

Verapamil Hydrochloride Injection Segment by Application

Hospital

Clinics

Other

Verapamil Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Verapamil Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Verapamil Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Verapamil Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Verapamil Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Verapamil Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Verapamil Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Verapamil Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Verapamil Hydrochloride Injection Industry Trends Table 2. Verapamil Hydrochloride Injection Industry Drivers Table 3. Verapamil Hydrochloride Injection Industry Opportunities and Challenges Table 4. Verapamil Hydrochloride Injection Industry Restraints Table 5. Global Verapamil Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Verapamil Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Verapamil Hydrochloride Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Verapamil Hydrochloride Injection Sales Market Share by Manufacturers Table 9. Global Verapamil Hydrochloride Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Verapamil Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Verapamil Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Verapamil Hydrochloride Injection Manufacturers, Product Type & Application Table 13. Global Verapamil Hydrochloride Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Verapamil Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Intravenous Injection Table 18. Global Verapamil Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Verapamil Hydrochloride Injection Sales by Type (2021-2026) & (k units) Table 20. Global Verapamil Hydrochloride Injection Sales by Type (2027-2032) & (k units) Table 21. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 22. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 23. Global Verapamil Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Verapamil Hydrochloride Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Verapamil Hydrochloride Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 27. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Other Table 31. Global Verapamil Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Verapamil Hydrochloride Injection Sales by Application (2021-2026) & (k units) Table 33. Global Verapamil Hydrochloride Injection Sales by Application (2027-2032) & (k units) Table 34. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 35. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 36. Global Verapamil Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Verapamil Hydrochloride Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Verapamil Hydrochloride Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 40. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 41. Global Verapamil Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Verapamil Hydrochloride Injection Sales by Region (2021-2026) & (k units) Table 43. Global Verapamil Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 44. Global Verapamil Hydrochloride Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Verapamil Hydrochloride Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 48. North America Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2027-2032) & (k units) Table 58. Global Verapamil Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Verapamil Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Verapamil Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 62. Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 63. ACIC Pharmaceuticals Company Information Table 64. ACIC Pharmaceuticals Business Overview Table 65. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio Table 67. ACIC Pharmaceuticals Recent Development Table 68. Exela Pharma Company Information Table 69. Exela Pharma Business Overview Table 70. Exela Pharma Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Exela Pharma Verapamil Hydrochloride Injection Product Portfolio Table 72. Exela Pharma Recent Development Table 73. Gland Pharma Company Information Table 74. Gland Pharma Business Overview Table 75. Gland Pharma Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Gland Pharma Verapamil Hydrochloride Injection Product Portfolio Table 77. Gland Pharma Recent Development Table 78. Mankind Pharma Company Information Table 79. Mankind Pharma Business Overview Table 80. Mankind Pharma Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mankind Pharma Verapamil Hydrochloride Injection Product Portfolio Table 82. Mankind Pharma Recent Development Table 83. Duoduo Pharmaceutical Company Information Table 84. Duoduo Pharmaceutical Business Overview Table 85. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 87. Duoduo Pharmaceutical Recent Development Table 88. Harbin Pharm. Group Sanjing Pharmaceutical Company Information Table 89. Harbin Pharm. Group Sanjing Pharmaceutical Business Overview Table 90. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 92. Harbin Pharm. Group Sanjing Pharmaceutical Recent Development Table 93. Hubei Weishi Company Information Table 94. Hubei Weishi Business Overview Table 95. Hubei Weishi Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hubei Weishi Verapamil Hydrochloride Injection Product Portfolio Table 97. Hubei Weishi Recent Development Table 98. China Res Double-Crane Company Information Table 99. China Res Double-Crane Business Overview Table 100. China Res Double-Crane Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. China Res Double-Crane Verapamil Hydrochloride Injection Product Portfolio Table 102. China Res Double-Crane Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Verapamil Hydrochloride Injection Product Portfolio Table 107. Pfizer Recent Development Table 108. Jilin Jinsheng Pharmaceutical Company Information Table 109. Jilin Jinsheng Pharmaceutical Business Overview Table 110. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 112. Jilin Jinsheng Pharmaceutical Recent Development Table 113. Jiangsu Langou Drug Company Information Table 114. Jiangsu Langou Drug Business Overview Table 115. Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jiangsu Langou Drug Verapamil Hydrochloride Injection Product Portfolio Table 117. Jiangsu Langou Drug Recent Development Table 118. Jiangsu Ruinian Qianjin Pharmacy Company Information Table 119. Jiangsu Ruinian Qianjin Pharmacy Business Overview Table 120. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product Portfolio Table 122. Jiangsu Ruinian Qianjin Pharmacy Recent Development Table 123. Zydus Pharmaceuticals Company Information Table 124. Zydus Pharmaceuticals Business Overview Table 125. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio Table 127. Zydus Pharmaceuticals Recent Development Table 128. Shanghai Harvest Pharmaceutical Company Information Table 129. Shanghai Harvest Pharmaceutical Business Overview Table 130. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 132. Shanghai Harvest Pharmaceutical Recent Development Table 133. Shiyao YINHU Pharmaceutical Company Information Table 134. Shiyao YINHU Pharmaceutical Business Overview Table 135. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 137. Shiyao YINHU Pharmaceutical Recent Development Table 138. Chia Tai-Tianqing Pharmaceutical Company Information Table 139. Chia Tai-Tianqing Pharmaceutical Business Overview Table 140. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio Table 142. Chia Tai-Tianqing Pharmaceutical Recent Development Table 143. Chongqing Yaoyou Pharmacy Company Information Table 144. Chongqing Yaoyou Pharmacy Business Overview Table 145. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product Portfolio Table 147. Chongqing Yaoyou Pharmacy Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Verapamil Hydrochloride Injection Distributors List Table 151. Verapamil Hydrochloride Injection Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Verapamil Hydrochloride Injection Product Image Figure 2. Global Verapamil Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Verapamil Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Verapamil Hydrochloride Injection Sales (2021-2032) & (k units) Figure 5. Global Verapamil Hydrochloride Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Verapamil Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Intravenous Injection Image Figure 10. Global Verapamil Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Verapamil Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 13. Global Verapamil Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Verapamil Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinics Image Figure 18. Other Image Figure 19. Global Verapamil Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Verapamil Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 22. Global Verapamil Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Verapamil Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 39. China Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Verapamil Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Verapamil Hydrochloride Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Verapamil Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Verapamil Hydrochloride Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Verapamil Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Verapamil Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Verapamil Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Verapamil Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Verapamil Hydrochloride Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Verapamil Hydrochloride Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intravenous Injection
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • ACIC Pharmaceuticals
  • Exela Pharma
  • Gland Pharma
  • Mankind Pharma
  • Duoduo Pharmaceutical
  • Harbin Pharm. Group Sanjing Pharmaceutical
  • Hubei Weishi
  • China Res Double-Crane
  • Pfizer
  • Jilin Jinsheng Pharmaceutical
  • Jiangsu Langou Drug
  • Jiangsu Ruinian Qianjin Pharmacy
  • Zydus Pharmaceuticals
  • Shanghai Harvest Pharmaceutical
  • Shiyao YINHU Pharmaceutical
  • Chia Tai-Tianqing Pharmaceutical
  • Chongqing Yaoyou Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Verapamil Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Verapamil Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Verapamil Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Verapamil Hydrochloride Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Verapamil Hydrochloride Injection Market Dynamics
  1. 2.1 Verapamil Hydrochloride Injection Industry Trends
  2. 2.2 Verapamil Hydrochloride Injection Industry Drivers
  3. 2.3 Verapamil Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Verapamil Hydrochloride Injection Industry Restraints
3 Verapamil Hydrochloride Injection Market by Manufacturers
  1. 3.1 Global Verapamil Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Verapamil Hydrochloride Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Verapamil Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Verapamil Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Verapamil Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Verapamil Hydrochloride Injection Manufacturers, Product Type & Application
  7. 3.7 Global Verapamil Hydrochloride Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Verapamil Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Verapamil Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Verapamil Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Verapamil Hydrochloride Injection Market by Type
  1. 4.1 Verapamil Hydrochloride Injection Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Intravenous Injection
  4. 4.2 Global Verapamil Hydrochloride Injection Sales by Type
  5. 4.2.1 Global Verapamil Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Verapamil Hydrochloride Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Verapamil Hydrochloride Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Verapamil Hydrochloride Injection Revenue by Type
  9. 4.3.1 Global Verapamil Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Verapamil Hydrochloride Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Verapamil Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Verapamil Hydrochloride Injection Market by Application
  1. 5.1 Verapamil Hydrochloride Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Verapamil Hydrochloride Injection Sales by Application
  6. 5.2.1 Global Verapamil Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Verapamil Hydrochloride Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Verapamil Hydrochloride Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Verapamil Hydrochloride Injection Revenue by Application
  10. 5.3.1 Global Verapamil Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Verapamil Hydrochloride Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Verapamil Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Verapamil Hydrochloride Injection Sales by Region
  1. 6.1 Global Verapamil Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Verapamil Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Verapamil Hydrochloride Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Verapamil Hydrochloride Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Verapamil Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Verapamil Hydrochloride Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Verapamil Hydrochloride Injection Revenue by Region
  1. 7.1 Global Verapamil Hydrochloride Injection Revenue by Region
  2. 7.1.1 Global Verapamil Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Verapamil Hydrochloride Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Verapamil Hydrochloride Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Verapamil Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Verapamil Hydrochloride Injection Revenue (2021-2032)
  8. 7.2.2 North America Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Verapamil Hydrochloride Injection Revenue (2021-2032)
  11. 7.3.2 Europe Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Verapamil Hydrochloride Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Verapamil Hydrochloride Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Verapamil Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ACIC Pharmaceuticals
  2. 8.1.1 ACIC Pharmaceuticals Company Information
  3. 8.1.2 ACIC Pharmaceuticals Business Overview
  4. 8.1.3 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
  6. 8.1.5 ACIC Pharmaceuticals Recent Developments
  7. 8.2 Exela Pharma
  8. 8.2.1 Exela Pharma Company Information
  9. 8.2.2 Exela Pharma Business Overview
  10. 8.2.3 Exela Pharma Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Exela Pharma Verapamil Hydrochloride Injection Product Portfolio
  12. 8.2.5 Exela Pharma Recent Developments
  13. 8.3 Gland Pharma
  14. 8.3.1 Gland Pharma Company Information
  15. 8.3.2 Gland Pharma Business Overview
  16. 8.3.3 Gland Pharma Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gland Pharma Verapamil Hydrochloride Injection Product Portfolio
  18. 8.3.5 Gland Pharma Recent Developments
  19. 8.4 Mankind Pharma
  20. 8.4.1 Mankind Pharma Company Information
  21. 8.4.2 Mankind Pharma Business Overview
  22. 8.4.3 Mankind Pharma Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mankind Pharma Verapamil Hydrochloride Injection Product Portfolio
  24. 8.4.5 Mankind Pharma Recent Developments
  25. 8.5 Duoduo Pharmaceutical
  26. 8.5.1 Duoduo Pharmaceutical Company Information
  27. 8.5.2 Duoduo Pharmaceutical Business Overview
  28. 8.5.3 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  30. 8.5.5 Duoduo Pharmaceutical Recent Developments
  31. 8.6 Harbin Pharm. Group Sanjing Pharmaceutical
  32. 8.6.1 Harbin Pharm. Group Sanjing Pharmaceutical Company Information
  33. 8.6.2 Harbin Pharm. Group Sanjing Pharmaceutical Business Overview
  34. 8.6.3 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  36. 8.6.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments
  37. 8.7 Hubei Weishi
  38. 8.7.1 Hubei Weishi Company Information
  39. 8.7.2 Hubei Weishi Business Overview
  40. 8.7.3 Hubei Weishi Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hubei Weishi Verapamil Hydrochloride Injection Product Portfolio
  42. 8.7.5 Hubei Weishi Recent Developments
  43. 8.8 China Res Double-Crane
  44. 8.8.1 China Res Double-Crane Company Information
  45. 8.8.2 China Res Double-Crane Business Overview
  46. 8.8.3 China Res Double-Crane Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Res Double-Crane Verapamil Hydrochloride Injection Product Portfolio
  48. 8.8.5 China Res Double-Crane Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Verapamil Hydrochloride Injection Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Jilin Jinsheng Pharmaceutical
  56. 8.10.1 Jilin Jinsheng Pharmaceutical Company Information
  57. 8.10.2 Jilin Jinsheng Pharmaceutical Business Overview
  58. 8.10.3 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  60. 8.10.5 Jilin Jinsheng Pharmaceutical Recent Developments
  61. 8.11 Jiangsu Langou Drug
  62. 8.11.1 Jiangsu Langou Drug Company Information
  63. 8.11.2 Jiangsu Langou Drug Business Overview
  64. 8.11.3 Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Langou Drug Verapamil Hydrochloride Injection Product Portfolio
  66. 8.11.5 Jiangsu Langou Drug Recent Developments
  67. 8.12 Jiangsu Ruinian Qianjin Pharmacy
  68. 8.12.1 Jiangsu Ruinian Qianjin Pharmacy Company Information
  69. 8.12.2 Jiangsu Ruinian Qianjin Pharmacy Business Overview
  70. 8.12.3 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product Portfolio
  72. 8.12.5 Jiangsu Ruinian Qianjin Pharmacy Recent Developments
  73. 8.13 Zydus Pharmaceuticals
  74. 8.13.1 Zydus Pharmaceuticals Company Information
  75. 8.13.2 Zydus Pharmaceuticals Business Overview
  76. 8.13.3 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product Portfolio
  78. 8.13.5 Zydus Pharmaceuticals Recent Developments
  79. 8.14 Shanghai Harvest Pharmaceutical
  80. 8.14.1 Shanghai Harvest Pharmaceutical Company Information
  81. 8.14.2 Shanghai Harvest Pharmaceutical Business Overview
  82. 8.14.3 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  84. 8.14.5 Shanghai Harvest Pharmaceutical Recent Developments
  85. 8.15 Shiyao YINHU Pharmaceutical
  86. 8.15.1 Shiyao YINHU Pharmaceutical Company Information
  87. 8.15.2 Shiyao YINHU Pharmaceutical Business Overview
  88. 8.15.3 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  90. 8.15.5 Shiyao YINHU Pharmaceutical Recent Developments
  91. 8.16 Chia Tai-Tianqing Pharmaceutical
  92. 8.16.1 Chia Tai-Tianqing Pharmaceutical Company Information
  93. 8.16.2 Chia Tai-Tianqing Pharmaceutical Business Overview
  94. 8.16.3 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product Portfolio
  96. 8.16.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  97. 8.17 Chongqing Yaoyou Pharmacy
  98. 8.17.1 Chongqing Yaoyou Pharmacy Company Information
  99. 8.17.2 Chongqing Yaoyou Pharmacy Business Overview
  100. 8.17.3 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product Portfolio
  102. 8.17.5 Chongqing Yaoyou Pharmacy Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Verapamil Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Verapamil Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Verapamil Hydrochloride Injection Production Mode & Process
  6. 9.2 Verapamil Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Verapamil Hydrochloride Injection Distributors
  9. 9.2.3 Verapamil Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst